Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.605, 2010-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Febuxostat comparable with allopurinol for gout
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Access to resources
Recommend
Rosuvastatin best cost option for dyslipidaemia in Mexico
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. :
Which strategy best cost option for vaginal agenesis?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 615, 2010-01 ,pp. :
Pegloticase: In Treatment-Refractory Chronic Gout
By Lyseng-Williamson Katherine A.
Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. :
Early intervention the best option in psychosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :